NeuroHagana Ltd
NeuroHagana Ltd is a biotechnology company based in Israel focused on developing neuroprotective treatments to prevent permanent disabilities from neurotrauma, including spinal cord injury, traumatic brain injury, and stroke. The company is advancing an immediate injectable treatment tested in animal models, with the mission to significantly improve the quality of life for neurotrauma victims and their families.
Industries
N/A
Products
A therapeutic solution designed to deliver immediate neuroprotection following various forms of neurotrauma, aiming to prevent permanent disability.
A therapeutic solution designed to deliver immediate neuroprotection following various forms of neurotrauma, aiming to prevent permanent disability.
Expertise Areas
- Neuroprotection
- Spinal cord injury treatment
- Acute neurotrauma intervention
- Glutamate toxicity mitigation
Key Technologies
- Blood glutamate scavenging
- Immediate injectable therapeutics
- Animal models for CNS injury
- Magnetic resonance spectroscopy for brain metabolite analysis
Key People
News & Updates
Scientific article detailing the effectiveness of blood glutamate scavenging in providing neuroprotective effects in spinal cord injury models.
Coverage of the development and demonstration of a therapeutic treatment potentially reducing nerve cell damage and improving mobility after spinal cord injury.
Study correlating increased glutamate levels with poorer neurological outcomes in stroke patients.
Feature on innovative treatments for spinal cord injury, including blood glutamate scavenging.
Analysis of the association between liver enzyme levels and stroke risk.
Research demonstrating efficacy of blood glutamate scavengers as a neuroprotective strategy in animal models.
Scientific article detailing the effectiveness of blood glutamate scavenging in providing neuroprotective effects in spinal cord injury models.
Coverage of the development and demonstration of a therapeutic treatment potentially reducing nerve cell damage and improving mobility after spinal cord injury.
Study correlating increased glutamate levels with poorer neurological outcomes in stroke patients.
Feature on innovative treatments for spinal cord injury, including blood glutamate scavenging.
Analysis of the association between liver enzyme levels and stroke risk.
Research demonstrating efficacy of blood glutamate scavengers as a neuroprotective strategy in animal models.